Does CBD Help With Anxiety?

Does CBD help with anxiety

Does CBD help with anxiety?

CBD is often used as a cure for many things, including anxiety. Recent studies have shown that CBD can reduce anxiety. That’s why it is getting popular among people for medicinal purpose.

CBD has gotten quite talks lately. Its been stocked by every medical food stores  now and the demand is also high among people. They say that CBD are cure for several health problems including anxiety.

Does CBD help with Anxiety?

We have just discussed about the popularity of CBD products for medicinal purpose, including anxiety. But we have not discussed how it really works. Some research has shown that it may work by affecting serotonin levels in the brain. Serotonin is a chemical in your body that plays a role in your:

  • Mood 
  • Sleep
  • Appetite
  • Behavior
  • Positive feelings
  • Learning and Memory

Serotonin is one of the chemical that is produced by our body for proper functioning of nervous system. Decrease in the level of serotonin results in anxiety and depression. Research suggests that increasing serotonin levels can help treat anxiety. Certain medications, such as antidepressants, work by regulating serotonin levels, and some studies suggest that CBD may work similarly to antidepressant and anti-anxiety medications.

Can CBD help with Depression?

Some studies say that CBD may help with depression. But most of these research are not done on humans. That’s why more research is needed on humans. Researchers and experts think that CBD acts in similar way for both anxiety and depression i.e. by altering serotonin level.

Result of Research on CBD and Anxiety

Due to CBD’s rising popularity, a number of studies have examined it as a treatment for anxiety. 

  • 2011 study showed that CBD reduced anxiety and discomfort during public speaking in people with social anxiety disorder. 

  • Another 2011 study found that CBD reduced anxiety symptoms in people with social anxiety disorder.

  • 2015 review of 49 studies found evidence that suggests CBD could help with generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder (PTSD).

  • 2019 study found that out of 11 patients with PTSD, 91% experienced reduced symptoms after taking CBD.

  • A study in 2019 used CBD to treat people who were struggling with anxiety and sleep. Almost 80% of people’s anxiety improved, and almost 70% reported improved sleep in the first month, but the results for sleep varied over time.

  • 2017 study didn’t find any evidence that CBD improved anxiety or paranoia, and it actually increased anxiety in some people.

These results are generally positive, but there are a few things to keep in mind. First, many of these studies have small sample sizes (even the ones with negative results). So the results don’t necessarily represent the general population. Second, these studies don’t look at the long-term effects of taking CBD for anxiety. This means we aren’t sure if taking the drug over time consistently reduces feelings of anxiety.


Doses of CBD for Anxiety

There’s no defined CBD dose for anxiety. But some study suggests that doses of 300 mg to 600 mg reduce anxiety in people with social anxiety disorder (SAD).

There are different forms of CBD products available in market now including:

  • Oils

  • Capsules

  • Drops

  • Teas

  • Vapor

  • Candies

Unfortunately, CBD products are not monitored by the FDA, and hence there’s no seal of approval on these products. Its in the hand of State Government to regulate and keep up with the CBD products.

Will CBD products get you high?

Pure CBD products don’t get you high. CBD and THC both act on same receptors in our brain. But TCH acts with higher degree than CBD which results in weakening of thinking and decision making ability.

It totally depends on the amount of THC present in the CBD products. Less the THC, better it results without more side effects. THC less than 0.3% is preferred.


CBD is currently considered as “miracle cure” element in medical field as it can heal different health related problems including anxiety. But due to poor regulation, they don’t contain the elements that they claim. Hence, it is always smart move to buy or consume CBD products which is authorized or verified from any kind of organization or authorized person.

cbdtheremedy and hemphelps have third-party tested products. This means these products are verified and suitable for consumers to consume. 

# 1 and Best CBD Oil for Anxiety

Cannabidiol or CBD is the most important compound found in the cannabis plant. It is also considered to be a very interesting product. The cannabis plant has been characterized as a chemical powerhouse producing more than 400 different compounds. CBD is not psychoactive which means it will not get people high. There has been no side effect found in humans from consuming CBD.  That’s why, CBD oil for anxiety is getting popular.

The US Farm Bill 2018 has allowed CBD, derived from hemp, to be sold in the United States without a prescription. The laws surrounding the use of CBD can vary per state based on the specified usage, whether medicinal or recreational. There are two important sources of CBD; the hemp plant and marijuana. Because the hemp plant has been associated with marijuana it has borne the social stigma. However, evolving research and more knowledge, CBD is now known as a reliever of aliments in the human body.

cbd for anxiety

This article explores whether CBD can help with anxiety. It also discusses on the best product to consider and outlines regulations and health considerations.


A plant whose scientific name is Cannabis sativa has two major parts:

  • CBD
  • THC

Although the main psychoactive constituent of Cannabis is tetrahydrocannabinol (THC), the plant is known to contain more than 500 compounds, among them at least 113 cannabinoids; however, most of these “minor” cannabinoids are only produced in trace amounts. Besides THC, another cannabinoid produced in high concentrations by some plants is cannabidiol (CBD), which is not psychoactive but has recently been shown to block the effect of THC in the nervous system. Differences in the chemical composition of Cannabis varieties may produce different effects in humans. Synthetic THC, called dronabinol, does not contain cannabidiol (CBD), cannabinol (CBN), or other cannabinoids, which is one reason why its pharmacological effects may differ significantly from those of natural Cannabis preparations.


Anxiety is your body’s natural response to stress. It’s a feeling of fear or apprehension about what’s to come. The first day of school, going to a job interview, or giving a speech may cause most people to feel fearful and nervous.

But if your feelings of anxiety are extreme, last for longer than six months, and are interfering with your life, you may have an anxiety disorder.

Symptoms of general anxiety include:

  • increased heart rate
  • rapid breathing
  • restlessness
  • trouble concentrating
  • difficulty falling asleep

If left untreated, anxiety can cause depression, heart disease, stroke, and sometimes premature death.


Research and Evidence of CBD for Anxiety

2019 case study Trusted Source notes that CBD products may benefit people who have anxiety disorders. The researchers studied the effects of CBD in 72 individuals with anxiety and poor sleep patterns.

After treatment with CBD, 79% of the participants experienced a decrease in anxiety levels, and 66.7% saw improved sleep scores. However, these scores fluctuated over time.

Authors of another study claim that there is not enough research to determine the appropriate dosage of CBD for anxiety-related disorders.

However, they examined the role of CBD in individuals with GAD, social anxiety disorder, and anxiety associated with post-traumatic stress disorder. They found that the participants tolerated CBD well and reported minimal adverse effects, such as fatigue and sedation.

CBD Oil For Anxiety

This CBD Oil is the best method of delivery to assist you in pain relief, decreased inflammation and providing a balanced mood. 

Place drops of the oil on your tongue to ingest this health-enhancing oil into your diet.  Our bottle of CBD oil is 24.8 mg per half a milliliter and 49.7 mg of oil to a full drop powerful or one milliliter.  The oil is distilled from organic hemp.


  • CBD Oil
  • Vegetable Glycerin
  • Natural Flavor


Try a half a dropper in the morning and a half a dropper at night.

The CBD Oil allows micro-dosing to occur during the day.



Third Party Lab Results on our CBD Oil is obtained regularly to assess the consistency of current content.


Current milligrams measured per 51.4 mg/ml of CBD broad spectrum.

CBD 4.01%, CBDa 0.00%, delta 9 THC 0.00%, THCa 0.00%.


CBD for Anxiety and Depression

CBD for Anxiety and depression , CBD oil works wonders


cbd for anxiety and depression

Canadian researchers examined 46 subjects who were close to the World Trade Center in New York City amid the September 11 fearmonger attacks. Twenty-four of these subjects suffered from PTSD (Post-traumatic stress disorder) following the attacks; 22 did not. 

The analysts found that individuals with PTSD had brought down serum levels of anandamide, an endogenous cannabinoid compound, contrasted with the individuals who did not hint at PTSD after 9/11. Intrinsic to all warm-blooded creatures, anandamide (our inward cannabis, in a manner of speaking) triggers similar mind receptors that are enacted by THC (tetrahydrocannabinol: The High Causer) and different parts of the pot plant. Moved in the cerebrum and focal sensory system, the cannabinoid receptor known as CB-1 intercedes an expansive scope of physiological capacities, including passionate learning, push adoption, and dread termination.

 Researchers have verified that ordinary CB-1 receptor flagging deactivates horrendous recollections and supplies us with the endowment of overlooking. Be that as it may, skewed CB-1 motioning, due to endocannabinoid cities (low serum levels of anandamide), brings about weakened read annihilation, aversive memory solidification, and perpetual uneasiness, the signs of PTSD.PTSD is one of the numerous confounding conditions that may emerge due to a dysfunctional endocannabinoid system. 

A 2009 report by Virginia Commonwealth University researchers perceived a connection between the dysregulation of the endocannabinoid framework and the improvement of epilepsy. Specialists at the University of Rome in Italy have archived low levels of anandamide in the cerebrospinal fluid in patients with un-treated recently analyzed fleeting flap epilepsy. 

Extra research has set up that clinical gloom is an endocannabinoid de cinchyillness. Canadian researcher and Rockefeller University post-doc Matthew Hill dissected the se-rumendocannabinoid content in discouraged ladies and found that it was “significantly diminished” contrasted and controlled. Neumeister takes note of that “endless anxiety creates an upregu-lation” of a critical metabolic compound—unsaturated fat amine hydro-lase, also called FAAH—which unequivocally in endocannabinoid flagging. 

Different proteins are engaged with the biosynthesis and creation of anandamide; different chemicals separate endogenous cannabinoid mixes. The FAAH compound is prominently in the metabolic breakdown of anandamide and a few other unsaturated fat delegateatoms. FAAH corrupts these scientists see this as a defensive reaction—the brief uptick of anandamide facilitates push and encourages homeostasis (an arrival to standard) by dialing down the generation of stress hormones through a procedure known as “pre-synaptic hindrance. 

“Be that as it may, incessant anxiety has a di reentered than intense anxiety. Perpetual anxiety exhausts endocannabinoid tone and sets the phase for all ways of disease. Constantly raised anxiety levels to support nervousness and significantly hurry the movement of Alzheimer’s dementia. Enthusiastic anxiety has been appeared to quicken the spread of disease. Stress likewise changes how we acclimatize fats. 

In 2012, a group of Brazilian researchers found that incessant anxiety diminishes CB-1 receptor official and articulation in the hippocampus, a zone of the cerebrum that assumes a noteworthy part in short and long haul memory consolidation. This has significant ramifications for treating PTSD. Endless anxiety weakens endocannabinoid flagging and hinders fear annihilation, as indicated by NYU Medical Center educator Alexander Neumeister. 

In a current scientific paper Neumeister contended for PTSD medicines that objective the endocannabinoid framework. Polymorphisms or bizarre amino corrosive arrangement rehashes in the qualities that encode FAAH are related to a penchant for medicating compulsion and predisposition toward different instinctions. In any case, it is the unusual up-control or potentially down-direction of qualities—more so than the qualities themselves—that drives malady vectors. Stress upset quality articulation.

Endless anxiety upregulates FAAH, and more FAAH brings about lower endocannabinoid levels. Then again, less FAAH implies more anandamide, and more anandamide implies lifted can-nabinoidreceptor flagging. Cannabidiol—CBD—is a non-psychoactive part of pot and hemp that upgrades endocannabinoid tone by repressing the FAAH compound. What’s more, this is only one of the ways that CBD indicates guarantee as a treatment for PTSD

Anxiety and depression remedy is CBD oil

Cannabis is much of the time utilized by patients with different sclerosis (MS) for muscle fit and torment, and in a trial model of MS low dosages of cannabinoids mitigated tremor. The vast majority of the controlled investigations have been done with THC instead of cannabis herb thus don’t copy the typical clinical circumstance. Little clinical investigations have affirmed the helpfulness of THC as a pain-relieving; CBD and CBG likewise have pain-relieving and calming impacts, demonstrating that there is the degree for creating drugs that don’t have the psychoactive properties of THC. 

Patients taking the engineered subsidiary nabilone for neurogenic agony really favored cannabis herb and revealed that it calmed torment as well as the related sorrow and uneasiness. Cannabinoids are compelling in chemotherapy-prompted emesis and nabilone has been authorized for this utilization for quite a while. At present, the manufactured cannabinoidHU211 is experiencing trials as a defensive specialist after mind injury. 

Episodic reports of cannabis utilize incorporate contextual analyses in headache and Tourette’s disorder, and as a treatment for asthma and glaucoma. Cannabis has a potential for clinical utilize frequently clouded by temperamental and simple narrative reports. The most imperative common cannabinoid is the psychoactive tetrahydrocannabinol (Δ9-THC); others incorporate cannabidiol (CBD) and cannabigerol (CBG). 

Not all the watched impacts can be credited to THC, and alternate constituents may likewise tweak its activity; for instance, CBD diminishes nervousness instigated by THC. An institutionalized concentrate of the herb might be in this manner be more advantageous by and by and clinical trial conventions have been attracted up to survey this. The instrument of activity is as yet not completely comprehended, despite the fact that cannabinoid receptors have been cloned and regular ligands recognized.

Characteristic materials are profoundly factors and various parts should be institutionalized to guarantee reproducible impacts. Immaculate characteristics and engineered mixes don’t have these detriments however might not have the general remedial impact on the herb. 

Aside from the smoking viewpoint, the wellbeing profile of cannabis is genuinely great. Be that as it may, unfriendly responses incorporate frenzy or nervousness assaults, which are more awful in the elderly and in ladies, and more improbable in youngsters. In spite of the fact that psychosis has been referred to as a result of cannabis utilize, an examination of psychiatric healing facility affirmations found no confirmation of this, notwithstanding, it might compound existing manifestations. 

The generally moderate disposal from the body of the cannabinoids has wellbeing suggestions for subjective undertakings, particularly driving and working apparatus; albeit driving disability with cannabis is just direct, there is a huge connection with liquor

CBD oil and anxiety

CBD oil or Cannabidiol in Humans—The Quest for Therapeutic Targets Simon Zhornitsky1and Stéphane Potvin2,*

1Multiple Sclerosis Clinic, Foothills Medical Centre, Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 1N4, Canada

2Fernand-Seguin Research Centre, Department of Psychiatry, Faculty of Medicine, Université deMontréal, Montreal, Quebec H1N 3V2, Canada*

Author to whom correspondence should be addressed; Email: Tel.: +1-514-251-4015;Fax: +1-514-251-2617.

Received: 20 April 2012; in revised form: 14 May 2012 / Accepted: 15 May 2012 / Published:21 May 201


Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing attention in medicine for its anxiolytic, antipsychotic, antiemetic, and anti-inflammatoryproperties. However, up to this point, a comprehensive literature review of the effects of CBD in humans is lacking. 

The aim of the present systematic review is to examine the randomized and crossover studies that administered CBD to healthy controls and to clinical patients. A systematic search was performed in the electronic databases PubMed and EMBASE using the keyword “cannabidiol”. 

Both monotherapy and combination studies (e.g., CBD + ∆9-THC) were included. A total of 34 studies were identified: 16 of these were experimental studies, conducted in healthy subjects, and 18 were conducted in clinical populations, including multiple sclerosis(six studies), schizophrenia and bipolar mania (four studies), social anxiety disorder (two studies), neuropathic and cancer pain (two studies), cancer anorexia (one study), Huntington’sdisease (one study), insomnia (one study), and epilepsy (one study). 

Experimental studies indicate that a high dose of inhaled/intravenous CBD is required to inhibit the effects of a lower dose of ∆9-THC. Moreover, some experimental and clinical studies suggest that oral/oromucosal CBD may prolong and/or intensify ∆9-THC-induced effects, whereas others suggest that it mayinhibit ∆9-THC-induced effects. Finally, preliminary clinical trials suggest that high-dose oralCBD (150–600 mg/d) may exert a therapeutic effect for social anxiety disorder, insomnia andepilepsy, but also that it may cause mental sedation.

Potential pharmacokinetic andpharmacodynamic explanations for these results are discussed.Keywords:cannabidiol; THC; cannabis; multiple sclerosis; pain; social anxiety disorder; epilepsy; insomnia; schizophrenia

  1. Introduction: The cannabis plant has been used by humans for thousands of years in medicine for its sedative/hypnotic, antidepressant, analgesic, anticonvulsant, antiemetic, anti-inflammatory, anti-spasmodic and appetite-stimulating effects [1]. The plant is composed of a complex chemical mixture that includes phytocannabinoids, terpenoids, flavanoids, steroids and enzymes [2].
  2. Phytocannabinoids—the most cannabis-specific of these constituents—bind to receptor sitesnormally activated by endogenous cannabinoids such as anadamide and 2-arachidonylglycerol(2-AG). It is widely believed the most psychoactive phytocannabinoid is delta-9-tetrahydrocannabinol (∆9-THC), which acts as a partial agonist at cannabinoid CB1receptors—found primarily in the central nervous system (CNS), and CB2receptors—found primarily oncells of the immune system [3,4]. However, apart from ∆9-THC, a number of otherphytocannabinoids are present in significant quantities in cannabis (e.g., cannabidiol, cannabinol, cannabichromene), and they may be responsible for some of the plant’s many putative medicinal properties. In animal studies, cannabidiol (CBD) has been receiving growing attention for its antiemetic, anticonvulsant, anti-inflammatory, and antipsychotic properties [5,6,7,8]. This broad range of therapeutic effects may be a result of CBD’s complex pharmacological mechanisms [9].Apart from ∆9-THC, CBD is the sole cannabinoid that has been thoroughly tested in humans innumerous controlled experimental studies as well as clinical trials for multiple sclerosis,neuropathic pain, schizophrenia, bipolar mania, social anxiety disorder, insomnia, Huntington’s disease and epilepsy. Surprisingly, however—up to this point—reviews and meta-analyses onthe topic of CBD in humans have not considered a large number of experimental and clinical studies that administered CBD-alone and/or in combination with ∆9-THC, versus ∆9-THC-alone[10,11,12]. The inclusion of these studies is essential to understanding the therapeutic potential of CBD and its mediation by pharmacokinetic and pharmacodynamic factors. The present review is aimed to comprehensively examine the effects of CBD in humans. We will begin with a brief overview of the pharmacokinetic and pharmacodynamic properties of CBD. Next, we will systematically examine the controlled experimental and clinical trials of CBD in order to elucidate its potential therapeutic role in human central nervous system (CNS) disorders